实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (1): 84-87.doi: 10.3969/j.issn.1672-5069.2025.01.022

• 肝衰竭 • 上一篇    下一篇

ACLF患者肺部感染发生率及预测因素分析*

孙敏, 张倩, 徐刚, 王加林, 何振文   

  1. 222200 南京市 东南大学医学院附属南京同仁医院老年病科(孙敏, 张倩, 王加林);普外科(徐刚);常州市金坛第一人民医院感染病科(何振文)
  • 收稿日期:2024-08-27 出版日期:2025-01-10 发布日期:2025-02-07
  • 通讯作者: 张倩,E-mail:270414037@qq.com
  • 作者简介:孙敏,女,31岁,大学本科,住院医师。E-mail:18852060497@163.com
  • 基金资助:
    *江苏省卫生健康委员会科研项目(编号:LKM2022083)

Prevalence and risk factors of pulmonary infection in patients with acute-on-chronic liver failure

Sun Min, Zhang Qian, Xu Gang, et al   

  1. Department of Geriatrics, Tongren Hospital Affiliated to Southeast University School of Medicine, Nanjing 222200, Jiangsu Province, China
  • Received:2024-08-27 Online:2025-01-10 Published:2025-02-07

摘要: 目的 分析慢加急性肝衰竭(ACLF)患者肺部感染发生率,并评估其发生的影响因素。方法 2020年1月~2024年1月我院收治的ACLF患者89例,治疗随访3个月。计算终末期肝病模型联合血清钠(MELD-Na)评分,应用多因素Logistic回归分析影响ACLF患者发生肺部感染的危险因素,应用受试者工作特征(ROC)曲线线性分析评估各指标的预测价值。结果 本组89例ACLF患者发生肺部感染31例(34.8%);肺部感染组年龄>65岁、合并糖尿病、侵入性操作和长期应用抗生素发生率率分别为61.3%、19.4%、61.3%和32.3%,均显著高于无肺部感染组(分别为32.8%、1.7%、34.5%和10.3%,P<0.05),血清白蛋白为(29.3±4.2)g/L,显著低于无肺部感染组【(33.8±4.9)g/L,P<0.05】,MELD-Na评分为(30.5±2.5)分,显著高于无肺部感染组【(27.1±2.0)分,P<0.05】;肺部感染组住院时间、28 d和90 d病死率分别为(29.8±3.1)d、41.9%和51.6%,显著长于或高于无肺部感染组【(21.2±2.7)d、12.1%和15.5%,P<0.05】;Logistic回归分析显示,年龄>65岁【OR=2.457,95%CI(1.283~4.707),P<0.05】、糖尿病【OR=2.807,95%CI(1.579~4.990),P<0.05】、侵入性操作【OR=3.071,95%CI(1.776~5.311),P<0.05】、长期应用抗生素【OR=2.983,95%CI(1.727~5.154),P<0.05】、白蛋白<31.2 g/L【OR=4.289,95%CI(2.779~6.619),P<0.05】和MELD-Na>29.0分【OR=3.927,95%CI(2.487~6.203),P<0.05】均为影响ACLF患者发生肺部感染的独立危险因素;ROC曲线分析显示,白蛋白和MELD-Na评分预测ACLF患者发生肺部感染具有临床实用意义(AUC=0.949,AUC=0.912,P<0.05)。结论 ACLF患者并发肺部感染的风险高,早期评估血清白蛋白水平和MELD-Na评分对预测肺部感染的发生有积极的指导作用。

关键词: 慢加急性肝衰竭, 肺部感染, 危险因素, 血清钠-终末期肝病模型, 预后

Abstract: Objective The aim of this study was to investigate prevalence and risk factors of pulmonary infection in patients with acute-on-chronic liver failure (ACLF). Methods 89 patients with ACLF were enrolled in our hospital between January 2020 and January 2024, and their clinical materials were retrospectively analyzed. The occurrence of pulmonary infection and short-term prognosis were recorded. Model for end-stage liver disease and serum sodium (MELD-Na) was calculated, multivariate Logistic regression analysis was applied to evaluate risk factors of pulmonary infection, and receiver operating characteristic (ROC) was used to predict prognosis. Results 31 patients (34.8%) had pulmonary infection among 89 patients with ACLF. In our series; the proportion of age older than 65 years, concomitant diabetes mellitus, invasive operation rate and long-term antibiotic use in patients with pulmonary infection group were 61.3%, 19.4%, 61.3% and 32.3%, all significantly higher than 32.8%, 1.7%, 34.5% and 10.3% (P<0.05), while serum albumin level was (29.3±4.2)g/L, much lower than [(33.8±4.9)g/L, P<0.05] and MELD-Na score was (30.5±2.5)points, much higher than [(27.1±2.0)points, P<0.05] in those without pulmonary infection; hospital stay, 28 d and 90 d mortality were (29.8±3.1)d, 41.9% and 51.6%, all much longer or greater than [(21.2±2.7)d, 12.1% and 15.5%, respectively, P<0.05] in those without pulmonary infection; Logistic regression analysis revealed that age older than 65 years [OR=2.457, 95%CI (1.283-4.707), P<0.05], diabetes mellitus [OR=2.807, 95%CI (1.579-4.990), P<0.05], invasive operation [OR=3.071, 95%CI (1.776-5.311), P<0.05], long-term antibiotic administration [OR=2.983, 95%CI (1.727-5.154), P<0.05], serum albumin level lower than 31.2 g/L [OR=4.289, 95%CI (2.779-6.619), P<0.05] and MELD-Na score greater than 29.0 points [OR=3.927, 95%CI (2.487-6.203), P<0.05] were all the independent risk factors for pulmonary infection; ROC analysis showed that serum albumin and MELD-Na score had statistical implication in predicting pulmonary infection in ACLF patients (AUC=0.949, AUC=0.912, P<0.05). Conclusion The risk of pulmonary infection is higher in ACLF patients. Surveillance of serum albumin levels and MELD-Na score might help clinicians take an appropriate measures to deal with it.

Key words: Acute-on-chronic liver failure, Pulmonary infection, Model for end-stage liver disease and serum sodium, Risk factors, Prognosis